Ninety One UK Ltd Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Ninety One UK Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 4th quarter, Holdings Channel reports. The fund owned 237,134 shares of the healthcare conglomerate’s stock after selling 7,363 shares during the period. Ninety One UK Ltd’s holdings in UnitedHealth Group were worth $119,957,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. E. Ohman J or Asset Management AB increased its holdings in UnitedHealth Group by 12.3% in the fourth quarter. E. Ohman J or Asset Management AB now owns 41,970 shares of the healthcare conglomerate’s stock valued at $21,231,000 after buying an additional 4,590 shares in the last quarter. Mather Group LLC. raised its holdings in UnitedHealth Group by 3.9% in the 4th quarter. Mather Group LLC. now owns 5,319 shares of the healthcare conglomerate’s stock worth $2,691,000 after purchasing an additional 198 shares during the period. Commonwealth Financial Services LLC grew its holdings in UnitedHealth Group by 26.3% in the fourth quarter. Commonwealth Financial Services LLC now owns 1,004 shares of the healthcare conglomerate’s stock valued at $508,000 after purchasing an additional 209 shares during the period. Rockline Wealth Management LLC raised its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Rockline Wealth Management LLC now owns 12,305 shares of the healthcare conglomerate’s stock worth $6,225,000 after buying an additional 192 shares during the period. Finally, Cullinan Associates Inc. grew its stake in UnitedHealth Group by 5.4% in the 4th quarter. Cullinan Associates Inc. now owns 18,498 shares of the healthcare conglomerate’s stock valued at $9,357,000 after acquiring an additional 950 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

Shares of UNH stock opened at $545.08 on Wednesday. The company has a 50-day moving average of $535.03 and a two-hundred day moving average of $565.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market cap of $501.63 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Finally, TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.